Christopher Bahl

Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Summit Partners LP (Summit Partners) is a private equity firm founded in 1984 by Gregory Avis, Roe Stamps and Stephen Woodsum. The firm is headquartered in Boston, Massachusetts.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA.

Sharpen Technologies, Inc. develops and sells multifaceted contact-center-management software. It offers sales acceleration, contact center, unified communications, integration services, reporting and analytics, and collaborative coaching. The company was founded by Cameron Weeks and Bracken Fields in 2007 and is headquartered in Indianapolis, IN.

Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Madison Technology LLC engages in computer facilities management. The company is headquartered in New York, USA.

Gilda's Club New York City, Inc. provides support services to cancer patients. Its programs include cancer support for all, offsite program, and programs for children and teens with cancer. The company was founded by Gene Wilder, Joanna Bull, Mandy Patinkin, and Joel Siegel in 1995 and is headquartered in New York, NY.

Zinio LLC operates as a digital publishing technology company. Its product ZINIO PRO converts print magazines to digital content through a SaaS platform that converts PDF to XML. The company was founded by Richard A. Maggiotto, Kevin B. McCurdy and John Kelleher in 2000 and is headquartered in New York, NY.

Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA.

Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA.

Cobro Ventures, Inc. ( Cobro Ventures ) is a venture capital firm founded in 2013 by Marc A. Cohen. The firm is headquartered in Arlington, Virginia.

Fintech Studios, Inc. provides cloud-based network of curated, disruptive FinTech apps, and big-data financial analytic products. curated fintech apps, investment research and big-data analytic services. It offers brokerage, trading, wealth management, banking and asset management, capital markets application, research, news, and financial analytics. The company was founded by Jim Tousignant and Andrew Haines in 2014 and is headquartered in New York, NY.

Part of Altamira Therapeutics Ltd., Trasir Therapeutics, Inc. develops specialty pharmaceutical products. The company is based in Tampa, FL. The company was founded by Samuel A. Wickline. Trasir Therapeutics was acquired by Altamira Therapeutics Ltd. on June 03, 2021 for $4.32 million.

Regenacy Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It develops treatments for diabetic and peripheral neuropathies. The firm provides treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors. It provides treatment for diseases such as sickle cell disease, ß-thalassemia, leukemia, and cognitive dysfunction in neurological disorders. The company was founded by Marc A. Cohen in December 2016 and is headquartered in Waltham, MA.

Platform Science, Inc. engages in the development and integration of hardware and software solutions for the transportation industry. Its digital supply chain technology enables customers and developers to unlock transportation data. The company was founded by Jake Fields and Jack Kennedy in 2015 and is headquartered in San Diego, CA.

Techsomed Medical Technologies Ltd. develops and manufactures ultrasound based real-time monitoring systems for thermal ablation procedures. It offers monitoring and prediction of the progression of tissue destruction during an ablation procedure. The company was founded by Yossi Abu and Eyal Melamed in 2012 and is headquartered in Rehovot, Israel.

Mana Therapeutics, Inc. provides clinical cell immune therapies that can eliminate cancer cells. The company was founded by Catherine Bollard, Patrick Hanley, C. Russell Y. Cruz and Marc Cohen and is headquartered in Arlington, VA.

Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA.

Bublup, Inc. engages in the development of a cloud platform for saving photos and documents. The company was founded on December 27, 2011 and is headquartered in Arlington, VA.

Lightchain Capital LLC operates as single family office of Rodger Riney. It offers venture capital, software development and data science and has worked for major banks, investment firms and startups. The company was founded by Leo Semmelmann and Jan-Erik Flentje in 2007and is headquartered in St. Louis, MO.

NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021.